Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diverging inflammasome signals in tumorigenesis and potential targeting
Rajendra Karki, Thirumala‐Devi Kanneganti
Nature reviews. Cancer (2019) Vol. 19, Iss. 4, pp. 197-214
Open Access | Times Cited: 537

Showing 1-25 of 537 citing articles:

Pyroptosis: mechanisms and diseases
Pian Yu, Xu Zhang, Nian Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1548
NLRP3 inflammasome in cancer and metabolic diseases
Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 550-559
Open Access | Times Cited: 750
The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Xiaojing Xia, Xin Wang, Zhe Cheng, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 9
Open Access | Times Cited: 727
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 715
Caspases in Cell Death, Inflammation, and Pyroptosis
Sannula Kesavardhana, R. K. Subbarao Malireddi, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 567-595
Open Access | Times Cited: 698
Long noncoding RNAs in cancer metastasis
Siyuan Liu, Ha X. Dang, Daniel A. Lim, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 446-460
Open Access | Times Cited: 501
ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis)
R. K. Subbarao Malireddi, Sannula Kesavardhana, Thirumala‐Devi Kanneganti
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 427
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
Kyohei Nakamura, Mark J. Smyth
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 1, pp. 1-12
Open Access | Times Cited: 400
Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
Min Zheng, Rajendra Karki, Peter Vogel, et al.
Cell (2020) Vol. 181, Iss. 3, pp. 674-687.e13
Open Access | Times Cited: 379
A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer
Ying Ye, Qinjin Dai, Hongbo Qi
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 353
DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome
Parimal Samir, Sannula Kesavardhana, Deanna M. Patmore, et al.
Nature (2019) Vol. 573, Iss. 7775, pp. 590-594
Open Access | Times Cited: 327
Immune modulatory effects of oncogenic KRAS in cancer
Shaima’a Hamarsheh, Olaf Groß, Tilman Brummer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 273
Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease
R. K. Subbarao Malireddi, Prajwal Gurung, Sannula Kesavardhana, et al.
The Journal of Experimental Medicine (2019) Vol. 217, Iss. 3
Open Access | Times Cited: 259
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109858-109858
Open Access | Times Cited: 257
The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics
Debasna Pritimanjari Panigrahi, Prakash Priyadarshi Praharaj, Chandra Sekhar Bhol, et al.
Seminars in Cancer Biology (2019) Vol. 66, pp. 45-58
Closed Access | Times Cited: 250
Toward targeting inflammasomes: insights into their regulation and activation
Shelbi Christgen, David E. Place, Thirumala‐Devi Kanneganti
Cell Research (2020) Vol. 30, Iss. 4, pp. 315-327
Open Access | Times Cited: 232
Role of AIM2 inflammasome in inflammatory diseases, cancer and infection
Bhesh Raj Sharma, Rajendra Karki, Thirumala‐Devi Kanneganti
European Journal of Immunology (2019) Vol. 49, Iss. 11, pp. 1998-2011
Open Access | Times Cited: 230
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 211
Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
Rajendra Karki, Bhesh Raj Sharma, Ein Lee, et al.
JCI Insight (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 202
Programming inflammatory cell death for therapy
Shelbi Christgen, Rebecca E. Tweedell, Thirumala‐Devi Kanneganti
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108010-108010
Open Access | Times Cited: 194
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Shaima’a Hamarsheh, Robert Zeiser
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 184
Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma
Wanli Lin, Ying Chen, Bomeng Wu, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 173
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Yuchen Wang, Hao Zhang, Chao Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 172
Inflammasomes as therapeutic targets in human diseases
Yangxin Li, Hui Huang, Bin Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 169
DNA Sensing in the Innate Immune Response
Benoit Briard, David E. Place, Thirumala‐Devi Kanneganti
Physiology (2020) Vol. 35, Iss. 2, pp. 112-124
Open Access | Times Cited: 165
Page 1 - Next Page

Scroll to top